Quantcast

Latest Janssen Pharmaceutica Stories

2014-09-19 23:00:13

Attorneys For Plaintiffs and Defendants Meet Regarding Risperdal Lawsuits That Allege Males Who Took the Antipsychotic Drug Developed Gynecomastia or Enlarged Male Breasts Columbus, OH (PRWEB) September 20, 2014 Nearly 780 Risperdal lawsuits are moving forward in the Philadelphia Court of Common Pleas where a meeting took place to discuss the next steps in the Risperdal side-effects complaints pending in the court’s mass tort program. Attorneys for the plaintiffs and defendants were...

2014-09-11 23:01:41

The Firm is representing numerous Risperdal lawsuit plaintiffs who allegedly developed gynecomastia, or male breast growth, due to their use of the antipsychotic drug. New York, New York (PRWEB) September 11, 2014 A Canadian project investigating the use of Risperdal (http://www.lawreward.com/risperdal/) and other antipsychotic medications in elderly dementia patients has reported positive outcomes when the drugs are reduced in this patient population, Bernstein Liebhard LLP reports....

2014-09-08 23:02:35

The Firm is representing a number of clients in Risperdal lawsuits that allege use of the antipsychotic medication caused gynecomastia, or male breast growth. New York, New York (PRWEB) September 08, 2014 Federal prosecutors have alleged that two California nursing homes inappropriately administered Risperdal (http://www.therisperdallawsuit.com/) and other medications to their patients, Bernstein Liebhard LLP reports. According to a lawsuit filed late last month in the U.S. District...

2014-09-08 08:29:59

Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease TORONTO, Sept. 8, 2014 /CNW/ - Janssen Inc. (Janssen) today announced it has signed an agreement, facilitated by the Johnson & Johnson Innovation center in California, with the University of Toronto's Centre for Collaborative Drug Research (CCDR) to form an open-source collaboration focused on novel therapeutic approaches to the treatment and management of mood disorders and Alzheimer's disease. The...

2014-08-26 23:03:41

The Firm is actively filing Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) August 26, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) mount in courts throughout the U.S., Bernstein Liebhard LLP notes the publication a new report that raises troubling questions about the use of psychotropic drugs among children in California’s...

2014-08-25 23:00:16

New Study Finding Supports Allegations in over 700 Risperdal Lawsuits of the Development of Male Breast Enlargement after Taking Risperdal, Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 26, 2014 A recently released study supports claims in Risperdal lawsuits that the antipsychotic drug Risperdal can cause the develop gynecomastia, or abnormal breast growth. In the study published on August 6, 2014, in the Journal of Clinical Psychopharmacology, researchers from the...

2014-08-25 08:27:57

Clinical Candidate COVA 322 and FynomAb® Technology Platform Further Strengthen Immunology Portfolio and Capabilities ZUG, Switzerland, Aug. 25, 2014 /PRNewswire/ -- Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb(®) technology platform. The...

2014-08-19 23:02:22

The Firm is representing men and boys in Risperdal lawsuits who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) August 19, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com) mount in U.S. courts, Bernstein Liebhard LLP notes the publication of a new study that suggests the use of atypical antipsychotic medications may increase the risk of acute kidney injury in elderly patients....

2014-08-16 23:02:22

The Firm is representing numerous clients in Risperdal lawsuits that allege gynecomastia, or male breast development, due to their use of the antipsychotic drug. New York, NY (PRWEB) August 16, 2014 A Risperdal (http://www.lawreward.com/risperdal/) meeting is scheduled to take place next month in the Philadelphia Court of Common Pleas, where hundreds of lawsuits over the antipsychotic medication are continuing to move forward, Bernstein Liebhard LLP reports. According to a Calendar...

2014-08-11 16:27:34

REDWOOD CITY, Calif., Aug. 11, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and six months ended June 30, 2014. On July 25, 2014, AcelRx announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company's new...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related